Try Alerts Free   |   Login
Health Care › In Vitro And In Vivo Diagnostic Substances

Intellia Therapeutics (NTLA) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 20 quarters since 2016. Compare with NTLA stock chart to see long term trends.

NTLA stock compared to

NTLA Income Statement

Revenue, Net:6595000
Revenue Per Share:0.12
Research & Development Expense:38231000
Total Operating Expenses:48994000
Operating Income:-42399000
Net Income:-42192000
Earnings Per Share, Basic:-0.69
Shares Outstanding, Basic Avg:55987000

NTLA Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:1602000
Change in Accounts Receiveable:913000
Net Cash from Operations:-40226000
Net Cash from Financing Activities:234093000
Property, Plant & Equipment Purchases:1006000
Net Cash from Investing Activities:-210918000
Net Change in Cash & Equivalents:-17051000

NTLA Balance Sheet

Cash and Cash Equivalents:164606000
Short-Term Investments:437351000
Accounts Receivable, Net:2130000
Total Current Assets:616517000
Property, Plant & Equipment, Net:15943000
Total Assets:676322000
Accounts Payable:10460000
Total Short-Term Liabilities:64254000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
5,645,009 sh
594,183 sh
12%
$112,224
$6,056
Vanguard Group Inc
4,376,799 sh
119,603 sh
3%
$87,010
-$2,476
Price T Rowe Associates Inc /Md/
1,458,005 sh
104,691 sh
8%
$28,985
$538
FMR LLC
1,378,964 sh
-229,667 sh
-14%
$27,414
-$6,400
Morgan Stanley
1,186,833 sh
406,842 sh
52%
$23,595
$7,199
Temasek Holdings (Private) Ltd
790,527 sh
 
$15,716
Northern Trust Corp
651,407 sh
179,775 sh
38%
$12,950
$3,036
Goldman Sachs Group Inc
540,092 sh
414,377 sh
330%
$10,737
$8,095
Charles Schwab Investment Management Inc
341,742 sh
40,937 sh
14%
$6,794
$471
Invesco Ltd.
316,701 sh
269,294 sh
568%
$6,296
$5,300
Artal Group S.A.
190,000 sh
-49,000 sh
-21%
$3,777
-$1,247
D. E. Shaw & Co., Inc.
171,969 sh
-22,492 sh
-12%
$3,419
-$669
Credit Suisse Ag/
128,373 sh
20,737 sh
19%
$2,553
$291
Royal Bank Of Canada
125,497 sh
-2,121 sh
-2%
$2,495
-$188
Legal & General Group Plc
93,549 sh
35,020 sh
60%
$1,860
$630
California State Teachers Retirement System
75,834 sh
9,749 sh
15%
$1,508
$119
State Of Wisconsin Investment Board
70,300 sh
9,400 sh
15%
$1,398
$118
UBS Asset Management Americas Inc
65,077 sh
5,136 sh
9%
$1,293,729
$33,768
Bank Of America Corp /De/
58,901 sh
33,925 sh
136%
$1,171
$646
Voya Investment Management LLC
16,569 sh
1,299 sh
9%
$329
$8

Data imported from Intellia Therapeutics Inc SEC filings. Check original filings before making any investment decision.